Financhill
Back

Citius Pharmaceuticals Vs. Moleculin Biotech Industry Stock Comparison

Sell
31

CTXR
Citius Pharmaceuticals

Last Price:
0.33
Seasonality Move:
21.66%
Sell
46

MBRX
Moleculin Biotech

Last Price:
3.09
Seasonality Move:
-0.2%
Sell
31
Citius Pharmaceuticals (CTXR) is a Sell

Is Citius Pharmaceuticals a Buy, Sell or Hold?

  • The current Citius Pharmaceuticals [CTXR] share price is $0.33. The Score for CTXR is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CTXR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Moleculin Biotech (MBRX) is a Sell

Is Moleculin Biotech a Buy, Sell or Hold?

  • The current Moleculin Biotech [MBRX] share price is $3.09. The Score for MBRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • MBRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CTXR Stock Price Chart

What is Citius Pharmaceuticals's stock price today?

  • The Citius Pharmaceuticals share price today is $0.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.

MBRX Stock Price Chart

What is Moleculin Biotech's stock price today?

  • The Moleculin Biotech share price today is $3.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MBRX is experiencing slight buying pressure.

CTXR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 39.61 Sell
Chaikin Money Flow: 1360852 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.35 - 0.41) Sell
Bollinger Bands (100): (0.39 - 0.77) Sell

MBRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 67.15 Buy
Chaikin Money Flow: 215786 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.38 - 2.68) Buy
Bollinger Bands (100): (2.2 - 3.38) Buy

CTXR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.39 Sell
20-day SMA: 0.38 Sell
50-day SMA: 0.44 Sell
200-day SMA: 0.65 Sell
8-day EMA: 0.39 Sell
20-day EMA: 0.39 Sell
50-day EMA: 0.45 Sell
200-day EMA: 0.63 Sell

MBRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.55 Buy
20-day SMA: 2.56 Buy
50-day SMA: 2.51 Buy
200-day SMA: 4.4 Sell
8-day EMA: 2.64 Buy
20-day EMA: 2.56 Buy
50-day EMA: 2.6 Buy
200-day EMA: 4.39 Sell

Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.

Moleculin Biotech Earnings Growth & MBRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.06 per share, and an increase next year of $8.81 per share.

Citius Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Moleculin Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):